The utility of stable isotope labeled (SIL) analogues in the bioanalysis of endogenous compounds by LC-MS applied to the study of bile acids in a metabolomics assay-Reference-Cited by-同舟云学术

The utility of stable isotope labeled (SIL) analogues in the bioanalysis of endogenous compounds by LC-MS applied to the study of bile acids in a metabolomics assay

Published:2016-06 Issue: Volume:503 Page:71-78
ISSN:0003-2697
Container-title:Analytical Biochemistry
language:en
Short-container-title:Analytical Biochemistry

Author:

Zheng Joanna J.,Shields Eric E.,Snow Kimberly J.,Nelson David M.,Olah Timothy V.,Reily Michael D.,Robertson Donald G.,Shipkova Petia A.,Stryker Steven A.,Xin Baomin,Drexler Dieter M.^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference24 articles.

1. A top-down systems biology view of microbiome–mammalian metabolic interactions in a mouse model;Martin;Mol. Syst. Biol.,2007

2. An overview of bile–acid synthesis, chemistry, and function;Stamp,2008

3. Bile acids as possible human carcinogens: new tricks from an old dog;Costarelli;Int. J. Food Sci. Nutr.,2009

4. Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer;Costarelli;Eur. J. Clin. Nutr.,2002

5. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method;Xu;Mol. Med. Rep.,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance;Metabolites;2024-03-22

2. An alternative approach to validation of liquid chromatography-mass spectrometry methods for the quantification of endogenous compounds;Journal of Chromatography A;2023-08

3. Coupling Stable Isotope Labeling and Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight-Tandem Mass Spectrometry for De Novo Mosquito Ovarian Lipid Studies;Analytical Chemistry;2022-04-14

4. Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278;Toxicology and Applied Pharmacology;2022-03

5. Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA₁) antagonists;TOXICOL APPL PHARM;2022